Local dose-dense chemotherapy for triple-negative breast cancer via minimally invasive implantation of 3D printed devices
Dose-dense chemotherapy is the preferred first-line therapy for triple-negative breast cancer (TNBC), a highly aggressive disease with a poor prognosis. This treatment uses the same drug doses as conventional chemotherapy but with shorter dosing intervals, allowing for promising clinical outcomes wi...
Saved in:
Main Authors: | Noehyun Myung (Author), Hyun-Wook Kang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer
by: Chueh-Yi Huang, et al.
Published: (2016) -
A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014) -
Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2020) -
Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014) -
Translating Minimally Invasive Glaucoma Surgery Devices
by: Richard M.H. Lee, et al.
Published: (2020)